Breast Cancer
Conference Coverage
Pilot study: Hybrid laser found effective for treating genitourinary syndrome of menopause
Further studies are important to improve the understanding of "laser dosimetry, frequency of treatments, and longevity of effect.
Conference Coverage
CONCERT: Better QoL but not survival with cabazitaxel in metastatic HER2– breast cancer
Conference Coverage
Genomic signature predicts safety of omitting RT in early breast cancer
Conference Coverage
ACE inhibitor prevents trastuzumab-associated LVEF decline after anthracyclines in BC treatment
Conference Coverage
Pregnancy effect on chemotherapy does not affect maternal breast cancer outcomes
Conference Coverage
ASCO 2021: Breast cancer sessions not to miss
Conference Coverage
'Exciting': Olaparib benefit also in early BRCA+ breast cancer
Conference Coverage
IL-6 levels predict distant breast cancer recurrence
Conference Coverage
Trastuzumab deruxtecan-related lung disease in MBC patients can occur anytime in first year
Article
Optimal Treatment for HR+/HER2- Breast Cancer Patients With Visceral Metastasis
Dr Adam Brufsky of the University of Pittsburgh reports on alternatives to chemotherapy for patients with HR+/HER2- breast...